Dickson Lab

This lab studies how microbial communities in the respiratory tract and gut contribute to illness and health, with a clinical focus on lung disease and critical illness. This is a translational laboratory, with tools spanning from molecular characterization of respiratory microbiota to ex vivo and animal models of lung injury and sepsis to prospective trials of human subjects. The lab’s long-term goal is to treat the microbiome as a therapeutic target for the prevention and treatment of lung disease and critical illness.